Nanocomposite Synthesis
Nanocomposite Synthesis - Related Videos
07:14
Synthesis of Graphene-Hydroxyapatite Nanocomposites for Potential Use in Bone Tissue Engineering
0 Views •
Cited by 4 •
2022
Novel nanocomposites of graphene nanoribbons and hydroxyapatite nanoparticles were prepared using solution-phase synthesis. These hybrids when employed in bioactive scaffolds can exhibit potential applications in tissue engineering and bone regeneration.
05:57
Fabrication of Antibacterial Graphene Oxide/Copper Nanocomposites
0 Views •
2024
Herein, we introduce graphene oxide/copper (GO/Cu) nanocomposites as an antibacterial nanomaterial. The antibacterial effectiveness of the GO/Cu nanocomposites was evaluated against both antibiotic-resistant gram-positive and gram-negative bacteria.
12:21
Preparation of Monodomain Liquid Crystal Elastomers and Liquid Crystal Elastomer Nanocomposites
0 Views •
Cited by 8 •
2016
We demonstrate the preparation of siloxane-based and epoxy-based liquid crystal elastomers (LCEs) and LCE nanocomposites. The LCEs are characterized with respect to reversible strain, liquid crystal ordering, and stiffness. As a potential application, we demonstrate their use as shape-responsive substrates in a custom device for active cell culture.
09:15
Synthesis of Ligand-free CdS Nanoparticles within a Sulfur Copolymer Matrix
0 Views •
2016
Herein we present a method to synthesize ligand-free cadmium sulfide (CdS) nanoparticles based on a unique sulfur copolymer. The sulfur copolymer operates as a high temperature solvent and a sulfur source during the nanoparticle synthesis and stabilizes the nanoparticles after the reaction.
13:34
Generation of Scalable, Metallic High-Aspect Ratio Nanocomposites in a Biological Liquid Medium
0 Views •
Cited by 13 •
2015
Here we present a protocol to synthesize novel, high-aspect ratio biocomposites under biological conditions and in liquid media. The biocomposites scale from nanometers to micrometers in diameter and length, respectively. Copper nanoparticles (CNPs) and copper sulfate combined with cystine are the key components for the synthesis.
FAQs
Interfaces between the matrix and nanoscale components help transfer the reinforcing or functional effects of the dispersed phase into the bulk material. Mixing, in situ polymerization, sol-gel conversion, and cross-linking can stabilize these interfaces while limiting agglomeration. Better interfacial control can improve reproducibility and help preserve properties such as mechanical reinforcement, electrical responsiveness, or controlled release.
Composition, nanoparticle or nanofiber size, surface chemistry, loading, and dispersion all influence the final material. These variables affect how evenly nanoscale components are distributed and how they interact with the surrounding matrix. Their combined effects determine performance, reproducibility, and biocompatibility, making careful control important when designing materials for bioengineering applications.
Agglomeration creates uneven distributions of nanoscale components, which can make material behavior less reproducible. Fabrication strategies that stabilize interfaces and improve dispersion help the matrix interact more consistently with nanoparticles, nanofibers, or nanosheets. This control matters because the resulting distribution influences mechanical, electrical, antimicrobial, drug-release, and cell-interactive performance.
Functional behavior changes with the selected matrix, nanoscale component, loading, particle size, surface chemistry, and dispersion. These choices can favor mechanical reinforcement, electrical responsiveness, antimicrobial behavior, controlled drug release, or cell-interactive surfaces. Consequently, nanocomposite synthesis is tailored to the intended bioengineering function rather than treated as a single standardized material process.
Common approaches include mixing, in situ polymerization, sol-gel conversion, and cross-linking. Each provides a route for combining nanoscale components with a polymer, ceramic, or metal matrix while helping stabilize the resulting interfaces. The selected approach should support adequate dispersion and limit agglomeration, because those factors affect reproducibility, biocompatibility, and functional performance.
Bioengineering applications include tissue-engineering scaffolds, biosensors, implant coatings, and therapeutic delivery systems. In these settings, the materials may provide mechanical reinforcement, electrical responsiveness, antimicrobial behavior, controlled drug release, or surfaces that interact with cells. The appropriate composition and processing conditions depend on which combination of structural, functional, and biological properties the application requires.